Accretion Nutraveda IPO allotment to be finalised today: Check steps to track status; latest GMP


Accretion Nutraveda IPO allotment: The initial public offering (IPO) of Accretion Nutraveda, which closed for bidding last week, is slated to announce the allotment status for its share sale.

Accretion Nutraveda IPO was open for bidding from January 28 to January 30. The allotment date for the SME offer is today, February 4. The IPO was oversubscribed by 1.83 times on the final day of the offer, with the qualified institutional buyer quota booked 1.01 times, the non-institutional investor (NII) segment 2.08 times and the retail investor portion 2.19 times.

Also Read | PhonePe IPO: 10 key risks investors should know from the updated DRHP

Accretion Nutraveda IPO was a fresh issue worth 24.77 crore, with no offer for sale component. The shares of the IPO were priced at 122 to 129 apiece.

The proceeds of the IPO will be utilised for the purchase of machinery to automate the existing manufacturing unit, setting up a new manufacturing facility, funding the company’s working capital requirements, and for general corporate purposes.

Accretion Nutraveda IPO allotment

Following the share sale conclusion, investors curious to know Accretion Nutraveda IPO allotment can check the status online by visiting the website of the registrar or the exchange.

Also Read | Hannah Joseph IPO listing: Shares debut at 7.6% discount to IPO price

Investors who received the allotment can expect the shares to be credited to the demat account on Tuesday, February 3, while those who did not receive allotment can expect a refund on the same day.

Steps to check Accretion Nutraveda IPO allotment on BSE SME

Since shares of Accretion Nutraveda will list on BSE SME, here’s how investors can check the allotment:

1. Head to the BSE website using this link: https://www.bseindia.com/investors/appli_check.aspx

2. Select issue type as ‘equity’

3. From the issue name dropdown, pick Accretion Nutraveda

4. Enter application number or PAN number

5. Select I am not a robot

Steps to check Accretion Nutraveda IPO allotment on KFin Technologies

KFin Tech is the registrar for Accretion Nutraveda IPO. Therefore, investors can check the allotment at its website by following these steps:

1. Visit IPO registrar’s website on this link – https://ipostatus.kfintech.com/

2. Choose ‘Accretion Nutraveda’ in the Select IPO dropdown menu

3. Select either Application No, Demat Account, or PAN

4. Enter the details as per the option selected

5. Enter the Captcha code and click on Submit

Accretion Nutraveda IPO GMP

Accretion Nutraveda IPO GMP today is Rs. This means that shares of Accretion Nutraveda are trading 6 above the offer price. At the current GMP and offer price, Accretion Nutraveda IPO listing could occur at 135, a premium of 4.65%.

Also Read | NSE IPO finally gets wings as Sebi gives no-objection certificate

About Accretion Nutraveda

Incorporated in 2021, Accretion Nutraveda is engaged in the manufacturing of Ayurvedic and Nutraceutical products in various dosage forms. It operates as a CDMO, distributing its products both in the domestic and international markets, such as Sri Lanka, Singapore, and the USA.

During FY26, its net profit tripled to 2.61 crore from 0.82 crore a year ago. Meanwhile, its total income jumped to 16.06 crore from 5.20 crore during the said period.

Disclaimer: This story is for educational purposes only. We advise investors to consult with certified experts before making any investment decisions.


Related Posts

Promoters’ ownership of India Inc slips below 50% for the first time since 2020. What does it mean?

So, who is driving this shift? Public shareholders backed largely by institutional investors such as mutual funds, foreign portfolio investors (FPIs) and individuals are steadily increasing their ownership in listed…

Pfizer shares slump 3.60% on fourth quarter loss, lower 2026 outlook

Shares of US drugmaker Pfizer Inc. slumped on Tuesday following a fourth quarter loss due to a large write-down. It also forecast lower revenues for 2026. The pharma giant highlighted…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Pakistan’s desperation to defeat India saw them out of U19 World Cup 2026: ‘That is not how sport is played’

  • By admin
  • February 4, 2026
  • 0 views
Pakistan’s desperation to defeat India saw them out of U19 World Cup 2026: ‘That is not how sport is played’

Promoters’ ownership of India Inc slips below 50% for the first time since 2020. What does it mean?

  • By admin
  • February 4, 2026
  • 0 views
Promoters’ ownership of India Inc slips below 50% for the first time since 2020. What does it mean?

Chipotle (CMG) Q4 2025 earnings

  • By admin
  • February 4, 2026
  • 0 views
Chipotle (CMG) Q4 2025 earnings

E-40 and Too $hort to bring Bay Area hip-hop to NFL Honors stage

  • By admin
  • February 4, 2026
  • 0 views
E-40 and Too $hort to bring Bay Area hip-hop to NFL Honors stage

Super Bowl Facts and Figures

  • By admin
  • February 4, 2026
  • 0 views
Super Bowl Facts and Figures

Fans spot ‘evidence’ of Ranveer Singh’s three-van demand in Dhurandhar end credits | Bollywood News

  • By admin
  • February 4, 2026
  • 0 views
Fans spot ‘evidence’ of Ranveer Singh’s three-van demand in Dhurandhar end credits | Bollywood News